Medicus Pharma Ltd. SEC filings MDCX
Medicus Pharma Ltd. has 343 filings in SEC EDGAR's recent list, going back to Oct 13, 2023. Its latest annual report, Form ARS, was filed on May 4, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Oct 26, 2026 | — |
| 424B3 | Prospectus | Oct 16, 2026 | — |
| 424B3 | Prospectus | Oct 7, 2026 | — |
| 424B3 | Prospectus | Sep 14, 2026 | — |
| 424B3 | Prospectus | Sep 3, 2026 | — |
| 424B3 | Prospectus | Aug 13, 2026 | — |
| 424B3 | Prospectus | Jun 4, 2026 | — |
| 424B3 | Prospectus | May 28, 2026 | — |
| 424B3 | Prospectus | May 14, 2026 | — |
| 424B3 | Prospectus | Apr 30, 2026 | — |
| 424B3 | Prospectus | Apr 27, 2026 | — |
| 424B3 | Prospectus | Apr 23, 2026 | — |
| POS AM | Form pos am | Mar 25, 2026 | — |
| POS AM | Form pos am | Mar 25, 2026 | — |
| POS AM | Form pos am | Mar 25, 2026 | — |
| 424B3 | Prospectus | Mar 25, 2026 | — |
| 424B3 | Prospectus | Mar 25, 2026 | — |
| 424B3 | Prospectus | Mar 25, 2026 | — |
| 424B3 | Prospectus | Mar 25, 2026 | — |
| 424B3 | Prospectus | Mar 6, 2026 | — |
| 424B3 | Prospectus | Mar 6, 2026 | — |
| 424B3 | Prospectus | Mar 6, 2026 | — |
| 424B3 | Prospectus | Mar 6, 2026 | — |
| S-3 | Shelf registration | Jan 30, 2026 | — |
| 424B5 | Prospectus supplement | Jan 2, 2026 | — |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| S-3 | Shelf registration | Dec 30, 2025 | — |
| 424B3 | Prospectus | Dec 8, 2025 | — |
| 424B3 | Prospectus | Dec 8, 2025 | — |
| 424B3 | Prospectus | Dec 8, 2025 | — |
| 424B3 | Prospectus | Dec 8, 2025 | — |
| 424B3 | Prospectus | Dec 8, 2025 | — |
| 424B3 | Prospectus | Dec 8, 2025 | — |
| 424B3 | Prospectus | Dec 5, 2025 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| S-1 | Registration statement | Nov 19, 2025 | — |
| 424B3 | Prospectus | Nov 17, 2025 | — |
| 424B3 | Prospectus | Nov 17, 2025 | — |
| 424B3 | Prospectus | Nov 17, 2025 | — |
| 424B3 | Prospectus | Nov 17, 2025 | — |
| 424B3 | Prospectus | Nov 17, 2025 | — |
| S-8 | Employee stock plan registration | Nov 14, 2025 | — |
| 424B3 | Prospectus | Oct 17, 2025 | — |
| 424B3 | Prospectus | Oct 17, 2025 | — |
| 424B3 | Prospectus | Oct 17, 2025 | — |
| S-1 | Registration statement | Sep 29, 2025 | — |
| S-1 | Registration statement | Sep 29, 2025 | — |
| 424B3 | Prospectus | Sep 18, 2025 | — |
| 424B3 | Prospectus | Sep 18, 2025 | — |
| 424B3 | Prospectus | Sep 18, 2025 | — |
| 424B3 | Prospectus | Sep 15, 2025 | — |
| 424B3 | Prospectus | Sep 15, 2025 | — |
| 424B3 | Prospectus | Sep 15, 2025 | — |
| 424B3 | Prospectus | Sep 2, 2025 | — |
| 424B3 | Prospectus | Sep 2, 2025 | — |
| 424B3 | Prospectus | Sep 2, 2025 | — |
| 424B3 | Prospectus | Aug 22, 2025 | — |
| 424B3 | Prospectus | Aug 22, 2025 | — |
| 424B3 | Prospectus | Aug 22, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| 424B3 | Prospectus | Jul 23, 2025 | — |
| 424B3 | Prospectus | Jul 23, 2025 | — |
| 424B3 | Prospectus | Jul 23, 2025 | — |
| 424B3 | Prospectus | Jul 14, 2025 | — |
| 424B3 | Prospectus | Jul 14, 2025 | — |
| 424B3 | Prospectus | Jul 14, 2025 | — |
| 424B3 | Prospectus | Jul 3, 2025 | — |
| 424B3 | Prospectus | Jul 3, 2025 | — |
| 424B3 | Prospectus | Jul 3, 2025 | — |
| 424B3 | Prospectus | Jun 30, 2025 | — |
| 424B3 | Prospectus | Jun 30, 2025 | — |
| 424B3 | Prospectus | Jun 30, 2025 | — |
| 424B3 | Prospectus | Jun 24, 2025 | — |
| 424B3 | Prospectus | Jun 24, 2025 | — |
| 424B3 | Prospectus | Jun 24, 2025 | — |
| 424B3 | Prospectus | Jun 20, 2025 | — |
| 424B3 | Prospectus | Jun 20, 2025 | — |
| 424B3 | Prospectus | Jun 20, 2025 | — |
| 424B3 | Prospectus | Jun 6, 2025 | — |
| 424B3 | Prospectus | Jun 6, 2025 | — |
| 424B3 | Prospectus | Jun 6, 2025 | — |
| 424B3 | Prospectus | Jun 3, 2025 | — |
| 424B3 | Prospectus | Jun 3, 2025 | — |
| 424B3 | Prospectus | Jun 3, 2025 | — |
| 424B3 | Prospectus | May 30, 2025 | — |
| 424B4 | Prospectus | May 30, 2025 | — |
| S-1 | Registration statement | May 27, 2025 | — |
| S-1 | Registration statement | May 27, 2025 | — |
| 424B3 | Prospectus | May 13, 2025 | — |
| 424B3 | Prospectus | May 5, 2025 | — |
| 424B3 | Prospectus | Apr 28, 2025 | — |
| POS AM | Form pos am | Apr 4, 2025 | — |
| 424B3 | Prospectus | Mar 11, 2025 | — |
| F-X | Form f-x | Feb 14, 2025 | — |
| 424B3 | Prospectus | Dec 26, 2024 | — |
| 424B3 | Prospectus | Nov 25, 2024 | — |
| 424B4 | Prospectus | Nov 15, 2024 | — |
| F-1/A | Form f-1/a | Oct 31, 2024 | — |
| F-1/A | Form f-1/a | Oct 29, 2024 | — |
| F-1/A | Form f-1/a | Oct 15, 2024 | — |
| F-1/A | Form f-1/a | Oct 1, 2024 | — |
| F-1/A | Form f-1/a | Sep 26, 2024 | — |
| F-1/A | Form f-1/a | Sep 23, 2024 | — |
| F-1/A | Form f-1/a | Aug 23, 2024 | — |
| F-1/A | Form f-1/a | Aug 9, 2024 | — |
| F-1/A | Form f-1/a | Jul 15, 2024 | — |
| F-1 | Registration statement (foreign issuer) | May 29, 2024 | — |
Showing 118 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MDCX (Nasdaq), MDCXW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Ontario, Canada
- Headquarters
- W. Conshohocken, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1997296
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.